Analyst Activity – Credit Suisse Group Initiates Coverage On Core Laboratories (NYSE:CLB) With a Outperform

ME Staff

6 years ago

Analyst Ratings For Core Laboratories (NYSE:CLB)

Today, Credit Suisse Group initiated coverage on Core Laboratories (NYSE:CLB) with a Outperform with a price target of $107.94.

Some recent analyst ratings include

3/15/2018-Credit Suisse Group initiated coverage with a Outperform rating.
3/13/2018-Piper Jaffray Companies initiated coverage with a Neutral rating.
1/11/2018-Deutsche Bank was Downgraded by analysts at Deutsche Bank from a “Buy ” rating to a ” Hold” rating. They now have a $109.00 price target on the stock, up previously from $116.30 .
1/9/2018-ABN Amro was Downgraded by analysts at ABN Amro from a “Buy ” rating to a ” Hold” rating.

Dividend information for Core Laboratories (NYSE:CLB)

Core Laboratories (NYSE:CLB) pays an annual dividend of $2.20 with a yield of 2.03% and an average dividend growth of 3.20% based on a 3 Year Average..

Dividend History for Core Laboratories (NYSE:CLB)

On 1/16/2018 Core Laboratories announced a Quarterly dividend of $0.55 0.00468284376330353% with an ex dividend date of 1/25/2018 which will be payable on 2/16/2018.
On 10/10/2017 Core Laboratories announced a quarterly dividend of $0.55 with an ex dividend date of 10/19/2017 which will be payable on 11/21/2017.
On 7/6/2017 Core Laboratories announced a Quarterly dividend of $0.55 2.11% with an ex dividend date of 7/13/2017 which will be payable on 8/14/2017.
On 4/19/2017 Core Laboratories announced a quarterly dividend of $0.55 1.98% with an ex dividend date of 4/27/2017 which will be payable on 5/23/2017.
On 1/10/2017 Core Laboratories announced a Quarterly dividend of $0.55 1.8% with an ex dividend date of 1/18/2017 which will be payable on 2/17/2017.
On 10/11/2016 Core Laboratories announced a Quarterly dividend of $0.55 1.95% with an ex dividend date of 10/19/2016 which will be payable on 11/22/2016.
On 7/7/2016 Core Laboratories announced a Quarterly dividend of $0.55 with an ex dividend date of 7/14/2016 which will be payable on 8/15/2016.

On 2/1/2017 Michael Straughen, Director, bought 106 with an average share price of $118.65 per share and the total transaction amounting to $12,576.90.
On 1/30/2017 Martha Z Carnes, Director, bought 200 with an average share price of $115.20 per share and the total transaction amounting to $23,040.00.
On 2/2/2016 Jan Willem Sodderland, Director, bought 300 with an average share price of $93.90 per share and the total transaction amounting to $28,170.00.
On 5/12/2015 Michael C Kearney, Director, sold 1,000 with an average share price of $128.52 per share and the total transaction amounting to $128,520.00.
On 11/17/2014 Mark F Elvig, VP, sold 1,000 with an average share price of $138.03 per share and the total transaction amounting to $138,030.00.
On 7/28/2014 Richard L Bergmark, CFO, bought 7,000 with an average share price of $147.31 per share and the total transaction amounting to $1,031,170.00.
On 3/7/2014 Michael Kearney, Director, sold 2,000 with an average share price of $193.00 per share and the total transaction amounting to $386,000.00.

Recent Trading Activity for Core Laboratories (NYSE:CLB)
Shares of Core Laboratories closed the previous trading session at with 108.20999908447266 shares trading hands.